Breast Cancer


FDA Approves Perjecta for Adjuvant Treatment of HER2-positive Breast Cancer (03-26-2018)

CancerConnect News: On December 20, 2017, the Food and Drug Administration granted regular approval to Perjeta (pertuzumab) for use in combination with Herceptin (trastuzumab) and chemotherapy as adjuvant treatment of patients with HER2-positive early... Continue Reading

At-home Genetic Testing may be Convenient, but it isn’t Complete (03-20-2018)

March 14, 2018 https://www.statnews.com/2018/03/14/genetic-testing-23andme-brca/   Home delivery for everything from fresh produce to custom-selected clothing has become a way of life for many Americans. While most home-delivery conveniences are generally... Continue Reading

FDA Approval for Verzenio™ as Initial Treatment for Advanced Breast Cancer (03-12-2018)

CancerConnect News: The U.S. Food and Drug Administration (FDA) has approved VerzenioTM (abemaciclib) in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor-positive... Continue Reading

Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer (02-21-2018)

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to new research published by a multi-institutional... Continue Reading

Five Common Sign & Symptoms of Breast Cancer (02-12-2018)

CancerConnect News: Breast cancer is a cancer that originates in the area of the breast, where cells replicate too quickly, causing a tumor. Breast cancer is most common in women, but I can also occur in men. Breast cancer is caused by an abnormality... Continue Reading

Breast Cancer Treatments May Increase Risk of Heart Disease (02-5-2018)

American Heart Association Scientific Statement Statement Highlights: Some breast cancer therapies can damage the heart and healthcare providers should carefully monitor breast cancer treatment effects on the heart. Breast cancer survivors, especially... Continue Reading

Lynparza Slows Spread of Inherited Breast Cancer Caused by BRCA Mutations: First Drug Approved for BRCA Breast Cancer (01-15-2018)

CancerConnect News: The US Food and Drug Administration (FDA) has extended the approval of Lynparza (olaparib) to include the treatment of metastatic breast cancer in patients who carry the specific inherited BRCA mutation.  These patients can be identified... Continue Reading

Updated Keytruda®/Halaven® Report Encouraging for Treatment of Triple Negative Breast Cancer (01-10-2018)

CancerConnect News: The investigative treatment combination including Keytruda® (pembrolizumab) plus Halaven® (eribulin) could provide a potential therapeutic option for patients with advanced triple-negative breast cancer (TNBC) whose disease has advanced... Continue Reading

Start 2018 Right: Plan for Cancer Screening and Save Lives! (01-5-2018)

Screening guidelines should initiate conversations with your healthcare team.  Charles H Weaver MD, Editor CancerConnect CancerConnect News: The goal of cancer screening is to find disease at early stages in people who are otherwise asymptomatic—before... Continue Reading

Oral Contraceptive Use Still Linked to Breast Cancer (12-27-2017)

Women who rely on birth control pills or contraceptive devices that release hormones face a small but significant increase in the risk for breast cancer, according to a large study published in the New England Journal of Medicine.1 This study is the first... Continue Reading

« Previous PageNext Page »